1. Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria

   • Roberto Fogari
   • Amedeo Mugellini
   • Paola Preti

   Pharmacodynamics 15 July 2005 Pages: 483 - 490

   

2. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population

   • Jónrit Halling
   • Maria S. Petersen
   • Kim Brøsen

   Pharmacogenetics 16 July 2005 Pages: 491 - 497

   

3. The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects

   • Jørgen G. Bramness
   • Svetlana Skurtveit
   • Jørg Mørland

   Pharmacogenetics 15 July 2005 Pages: 499 - 506

   

4. Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation

   • Christine E. Staatz
   • Stephen B. Duffull
   • Susan E. Tett

   Pharmacokinetics and Disposition 28 July 2005 Pages: 507 - 516

   

5. Pharmacokinetics and transplacental distribution of fentanyl in epidural anesthesia for normal pregnant women

   • Elaine Christine Dantas Moisés
   • Luciana de Barros Duarte
   • Sérgio Pereira da Cunha

   Pharmacokinetics and Disposition 15 July 2005 Pages: 517 - 522

   

6. Different pharmacokinetics of tramadol in mothers treated for labour pain and in their neonates

   • H. L. Claahsen-van der Grinten
   • I. Verbruggen
   • L. A. A. Kollée

   Pharmacokinetics and Disposition 09 July 2005 Pages: 523 - 529

   

7. Comparison of information on the pharmacokinetic interactions of Ca antagonists in the package inserts from three countries (Japan, USA and UK)

   • Mitsuo Saito
   • Mutsuko Hirata-Koizumi
   • Ryuichi Hasegawa

   Pharmacoepidemiology and Prescription 23 July 2005 Pages: 531 - 536

8. Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions

   • Said Benahmed
   • Marie Christine Picot
   • Pascal Demoly

   Pharmacoepidemiology and Prescription 15 July 2005 Pages: 537 - 541

9. Mirtazapine in drug-induced excessive sweating

   • Ansgar Buecking
   • Caroline Louise Vandeleur
   • Daniele Fabio Zullino

   Case Report 09 July 2005 Pages: 543 - 544

10. Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients

    • Elena Seminari
    • Monica Guffanti
    • Adriano Lazzarin

    Short Communication 23 July 2005 Pages: 545 - 549

    

11. MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers

    • Rafael de la Torre
    • Magí Farré
    • Jordi Camí

    Short Communication 23 July 2005 Pages: 551 - 554

12. Can colchicine potentiate the anticoagulant effect of fluindione?

    • Valérie Gras-Champel
    • Patrick Ohlmann
    • Michel Andréjak

    Letter to the Editors 09 July 2005 Pages: 555 - 556

13. Reply to EJCP 2004-0275 and 2004-0350

    • M. Oberbaum
    • SR. Singer
    • D. Branski

    Erratum 22 July 2005 Pages: 557 - 557